Correction to: Nature Communications https://doi.org/10.1038/s41467-021-24905-z, published online 30 July 2021
The original version of the Supplementary Information associated with this Article included an incorrect Supplementary Data 1 file, in which sequences were duplicated. The HTML has been updated to include a corrected version of Supplementary Data 1; the original incorrect version of Supplementary Data 1 can be found as Supplementary Information associated with this Correction.
Author information
Authors and Affiliations
Corresponding authors
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Li, T., Cai, H., Yao, H. et al. Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection. Nat Commun 13, 4359 (2022). https://doi.org/10.1038/s41467-022-32074-w
Published:
DOI: https://doi.org/10.1038/s41467-022-32074-w
This article is cited by
-
The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics
Molecular Diagnosis & Therapy (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
